The Venowave is manufactured and distributed by Saringer Life Science Technologies Inc. a privately held Canadian company. For further information please visit www.saringer.com

Management Team

Saringer Life Science Technologies Inc. has assembled a team of experienced and qualified individuals with direct involvement in the commercialization of medical products in North America and abroad. The company has also engaged outside advisors and consultants with many years of experience and expertise.

John Saringer - President and CEO John Saringer is a successful engineer, inventor and entrepreneur. He began his career as an academic, doing biomedical research and teaching statistics to engineering students at the University of Toronto. John has eighteen U.S. and Canadian patents to his credit, and more pending, and over 30 patents from other jurisdictions. Having worked with various medical device technologies over the past thirty years, John brings technical and design leadership to Saringer Life Science Technologies.

Dayna Switzer- General Manager Dayna Switzer began her career working with a variety of cosmetic companies from France, Italy and India. She has always worked closely with organizations and customers from around the world. In 2003 Mrs. Switzer together with her husband co founded an Immigration Consulting Firm which successfully brought over 900 foreign workers to Canada. While Director of International Recruiting at Trust Immigration Consulting, she met engineer, inventor and entrepreneur John Saringer. Dayna was hired to act as the company's International Sales Manager. She became an integral part of the launch of Saringer's products, initiated many regulatory licensing processes, commenced customer operations and developed the company's direct and indirect sales teams. Today as General Manager, she oversees all major operations, from finance, human resources, logistics, sales and marketing, clinical and health affairs, all operational support and is responsible for overseeing the regulatory aspects of the company.

Professional Advisors:

Dr. Jack Hirsh, Chief Scientific Officer and Professor Emeritus, McMaster University

Dr. Jack Hirsh, professor emeritus in medicine and director of the Henderson Research Centre, is an internationally recognized clinician and scientist in anti-coagulant therapy and thrombosis. Dr. Hirsh is a member of the Order of Canada, a recipient of the International Gairdner Research Award, and a Fellow of the Royal Society of Canada, Dr. Hirsh has developed a world-renowned program for the diagnosis, prevention and treatment of thrombosis (abnormal blood clots) and atherosclerosis. Dr. Hirsh has been instrumental in the planning and execution of the clinical trials for both the Venowave and the ICE-O-therm.

Dr. Robert Kaplan, Buffalo Pediatric Associates

Dr. Kaplan is a Clinical Associate Professor within the Department of Pediatrics at the University at Buffalo School of Medicine and Biomedical Sciences, and is an Attending Physician with Buffalo Pediatric Associates. Dr. Kaplan is a shareholder in Saringer Life Science Technologies and has been actively leading the strategic Clinical Reference Network on behalf of the company.

Dr. Sonia Anand , Associate Professor of Cardiology, and Director of the Vascular Medicine Clinic, Hamilton Health Sciences

Dr. Anand is a Professor of Medicine and Epidemiology at McMaster University, the Director of McMaster Population Genomics Program and a vascular medicine specialist. She recently received the Canada Research Chair in Ethnic Diversity and Cardiovascular Disease. She also holds both the new Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research, as well as the Eli Lily/May Cohen Chair in Women's Health Research at McMaster. Her present research focuses upon the environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease, and peripheral vascular disease.

Dr. John Eikelboom, Associate Professor in the Department of Medicine at McMaster University in Hamilton, Ontario

After earning his MBBS degree at the University of Western Australia Medical School, Australia, he completed training in Internal Medicine and Haematology at Royal Perth Hospital, Australia, and trained in Epidemiology and Thrombosis Medicine at McMaster University. He holds a Canada Research Chair in Cardiovascular Medicine from the Canadian Institutes for Health Research. Dr Eikelboom's current research focuses on variable response to antiplatelet therapy, antithrombotic therapy in atrial fibrillation, and mechanisms and prognosis of bleeding. He has published more than 150 peer-reviewed papers. He is a member of the Editorial Board for Stroke and on the Advisory Board for the Journal of Thrombosis and Haemostasis.

Dr. Jeff Ginsberg - Professor, Division of Hematology and Thromboembolism, Department of Medicine at McMaster University in Hamilton

Dr Ginsberg was the Director of the Clinical Thromboembolism Group (CTG) at the Henderson Research Centre from 1999 to 2005. He graduated from medical school at the University of Ottawa in 1978 and was elected into the Alpha Omega Alpha Medical Society. After a brief stint as a military physician, he completed Internal Medicine and Hematology training at the University of Toronto. He came to Hamilton in 1986 as a Research Fellow of the Heart & Stroke Foundation of Canada under the supervision of Dr Hirsh and became the Chief of the Thromboembolism Service at Chedoke-McMaster Hospitals in 1988. Since then, he has had continuous personnel support, first as a Research Scholar of the Heart and Stroke Foundation of Canada and then, for the last 7 years as a Career Investigator of the Heart and Stroke Foundation of Ontario. He also holds a Research Chair from CIHR/UI and has been awarded the Fortino's Distinguished Scientist Award, a five year award for outstanding research of the Heart and Stroke Foundation of Ontario. In September 2005 he received the inaugural award of the David Braley and Nancy Gordon Chair in Thromboembolic Disease. He has been successful in obtaining many peer-reviewed grants from H&SFO, CIHR/MRC, NHRDP and PSI. In addition, he has given many plenary talks and Chaired many sessions at international meetings, such as ASH, ISTH, ACCP and AHA. He has trained 12 research fellows, many of whom have gone on to become successful, independent investigators. Dr Ginsberg's publication list is extensive with 416 peer-reviewed publications. Many of these have appeared in high profile journals such as the New England Journal of Medicine, Annals of Internal Medicine, JAMA and Archives of Internal Medicine. He is a co-editor of a book entitled Critical Decisions in Thrombosis and Hemostasis and Editor-in-Chief of the journal Thrombosis Research.